Cubist Systematic Strategies, LLC Vista Gen Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.07 $3,989 - $30,492	-28,498 Reduced 99.99%	2 $0
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $4,755 - $9,348	5,404 Added 23.4%	28,500 $25,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $26,329 - $48,270	23,096 New	23,096 $29,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $24,716 - $40,848	-14,800 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $224,942 - $296,203	-85,856 Reduced 85.3%	14,800 $41,000

Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $4,637 - $7,452	2,366 Added 2.41%	100,656 $317,000
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $148,554 - $232,656	78,600 Added 399.19%	98,290 $209,000
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $12,798 - $38,198	19,690 New	19,690 $38,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.